Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2003;52:1555-1561; doi:10.1136/gut.52.11.1555
Copyright © 2003 BMJ Publishing Group Ltd & British Society of Gastroenterology.

STOMACH

Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans

A Foxx-Orenstein, M Camilleri, D Stephens, D Burton

Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER) Program, Mayo Clinic, Rochester, MN, USA

Correspondence to:
Correspondence to:
Professor M Camilleri
Mayo Clinic, Charlton 8-110, 200 First Street SW, Rochester, MN 55905, USA; camilleri.michael{at}mayo.edu

Background: Pharmacological approaches to alter satiation may have an impact on functional upper gastrointestinal disorders and potentially change food intake in obesity.

Aim: Our aim was to compare the effects of two doses of octreotide and placebo on postprandial symptoms, gastric accommodation, and gastric emptying using validated non-invasive techniques.

Methods: In a randomised, parallel group, two dose, double blind, placebo controlled study, 39 healthy participants (13 per group) were randomised to 30 or 100 µg octreotide or placebo, administered subcutaneously, 30 minutes before each study. Studies were performed on three separate days and included scintigraphic gastric emptying of solids and liquids, 99mTc SPECT imaging to measure fasting stomach volume and gastric accommodation following a 300 ml Ensure meal, and a standardised nutrient drink test to measure maximum tolerated volume and postprandial symptoms.

Results: Relative to placebo, both doses of octreotide delayed gastric emptying of solids (not liquids), increased fasting gastric volume, reduced the change in gastric volume post meal, and decreased the sensation of fullness after a satiating meal.

Conclusion: The somatostatin analogue octreotide significantly alters human gastric functions, including inhibition of the normal reflex responses of gastric volume increase and emptying of the meal. These pharmacological effects suggest studies of the medication in disorders of satiation, including obesity and dyspepsia, are warranted.

Keywords: octreotide; somatostatin analogue; gastric emptying; accommodation; single photon emission computed tomography (SPECT)

Abbreviations: SPECT, single photon emission computed tomography; VAS, visual analogue scale; IQR, interquartile range


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Bray, G. A., Greenway, F. L. (2007). Pharmacological Treatment of the Overweight Patient. Pharmacol. Rev. 59: 151-184 [Full Text]  
  • Andrews, C. N., Bharucha, A. E., Camilleri, M., Low, P. A., Seide, B., Burton, D., Baxter, K., Zinsmeister, A. R. (2007). Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am. J. Physiol. Gastrointest. Liver Physiol. 292: G1359-G1365 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs